These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 14983940)
1. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. O'Connell FP; Pinkus JL; Pinkus GS Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940 [TBL] [Abstract][Full Text] [Related]
2. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261 [TBL] [Abstract][Full Text] [Related]
3. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879 [TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177 [TBL] [Abstract][Full Text] [Related]
5. Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas. Saqi A; Yun SS; Yu GH; Alexis D; Taub RN; Powell CA; Borczuk AC Diagn Cytopathol; 2005 Aug; 33(2):65-70. PubMed ID: 16007640 [TBL] [Abstract][Full Text] [Related]
6. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis. Martín P; Santón A; Bellas C Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients. Kara IO; Sahin B; Paydas S; Cetiner S Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184 [TBL] [Abstract][Full Text] [Related]
8. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens. Costes V; Magen V; Legouffe E; Durand L; Baldet P; Rossi JF; Klein B; Brochier J Hum Pathol; 1999 Dec; 30(12):1405-11. PubMed ID: 10667416 [TBL] [Abstract][Full Text] [Related]
9. Plasmablastic lymphoma: a clinicopathologic correlation. Folk GS; Abbondanzo SL; Childers EL; Foss RD Ann Diagn Pathol; 2006 Feb; 10(1):8-12. PubMed ID: 16414538 [TBL] [Abstract][Full Text] [Related]
10. Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms. Nascimento AF; Pinkus JL; Pinkus GS Am J Clin Pathol; 2004 May; 121(5):709-17. PubMed ID: 15151211 [TBL] [Abstract][Full Text] [Related]
11. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis. Chen CL; Ou DL Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936 [TBL] [Abstract][Full Text] [Related]
12. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Bayer-Garner IB; Korourian S Mod Pathol; 2001 Sep; 14(9):877-9. PubMed ID: 11557783 [TBL] [Abstract][Full Text] [Related]
13. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298 [TBL] [Abstract][Full Text] [Related]
14. Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. Chu PG; Arber DA; Weiss LM Am J Clin Pathol; 2003 Jul; 120(1):64-70. PubMed ID: 12866374 [TBL] [Abstract][Full Text] [Related]
15. [Syndecan-1 (CD138): an immunohistochemical marker of plasma cell tumors]. Fakan F; Boudová L; Hejda C Cesk Patol; 2002 Jan; 38(1):33-6. PubMed ID: 11933459 [TBL] [Abstract][Full Text] [Related]
16. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054 [TBL] [Abstract][Full Text] [Related]
17. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation. Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517 [TBL] [Abstract][Full Text] [Related]
18. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray. Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6. Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780 [TBL] [Abstract][Full Text] [Related]
20. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]